CD4


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 23 03 2019
accepted: 28 06 2019
entrez: 30 7 2019
pubmed: 30 7 2019
medline: 21 10 2020
Statut: epublish

Résumé

Systemic lupus erythematosus (SLE) is an autoimmune disease that involves multiple immune cell subsets. We analyzed immune cell subsets in human peripheral blood mononuclear cells (PBMC) in order to identify the cells that are significantly associated with SLE disease activity and treatment. The frequencies of various subsets of CD4

Identifiants

pubmed: 31354747
doi: 10.3389/fimmu.2019.01619
pmc: PMC6640175
doi:

Substances chimiques

Biomarkers 0
Interleukin-2 Receptor alpha Subunit 0
ALG3 protein, human EC 2.4.1.-
Mannosyltransferases EC 2.4.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1619

Références

J Immunol. 2000 Nov 15;165(10):5970-9
pubmed: 11067960
J Immunol. 2001 Aug 15;167(4):2361-9
pubmed: 11490026
J Exp Med. 2002 Nov 18;196(10):1335-46
pubmed: 12438424
Science. 2003 Feb 14;299(5609):1057-61
pubmed: 12522256
Arthritis Rheum. 2003 May;48(5):1332-42
pubmed: 12746906
Immunity. 2004 Oct;21(4):503-13
pubmed: 15485628
Arthritis Rheum. 1992 Jun;35(6):630-40
pubmed: 1599520
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64
pubmed: 16617117
J Exp Med. 2006 Jul 10;203(7):1701-11
pubmed: 16818678
Blood. 2007 Oct 15;110(8):2983-90
pubmed: 17644734
Ann Rheum Dis. 2008 May;67(5):664-71
pubmed: 17728327
Eur J Clin Invest. 2007 Dec;37(12):987-96
pubmed: 18036033
Lupus. 2008 Jan;17(1):26-33
pubmed: 18089680
Arthritis Rheum. 2008 Mar;58(3):801-12
pubmed: 18311820
Blood. 2008 Sep 15;112(6):2340-52
pubmed: 18617638
Clin Exp Immunol. 2008 Nov;154(2):247-54
pubmed: 18795942
Blood. 2009 Apr 30;113(18):4240-9
pubmed: 19171879
J Immunother. 2009 Feb-Mar;32(2):101-8
pubmed: 19238008
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4793-8
pubmed: 19273860
Arthritis Rheum. 2009 May;60(5):1472-83
pubmed: 19404966
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8635-40
pubmed: 19439651
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13974-9
pubmed: 19666526
Ann Rheum Dis. 2010 Jan;69 Suppl 1:i65-66
pubmed: 19995748
Arthritis Rheum. 2010 Jan;62(1):234-44
pubmed: 20039395
J Autoimmun. 2010 Nov;35(3):269-75
pubmed: 20638240
Rheumatology (Oxford). 2011 Aug;50(8):1366-72
pubmed: 21489974
J Invest Dermatol. 2011 Sep;131(9):1853-60
pubmed: 21654831
Trends Immunol. 2011 Aug;32(8):388-94
pubmed: 21752714
Nat Rev Immunol. 2012 Feb 17;12(3):191-200
pubmed: 22343568
Ann Rheum Dis. 2013 Sep 1;72(9):1549-58
pubmed: 23264341
Blood. 2013 Apr 4;121(14):2647-58
pubmed: 23355538
Nature. 2013 Apr 25;496(7446):461-8
pubmed: 23467089
Nat Med. 2013 Jun;19(6):739-46
pubmed: 23624599
PLoS One. 2013 Jun 11;8(6):e64531
pubmed: 23776439
Arthritis Rheum. 2013 Nov;65(11):2898-906
pubmed: 23925905
Front Immunol. 2013 Oct 02;4:306
pubmed: 24106491
Semin Immunol. 2013 Nov 15;25(4):305-12
pubmed: 24211039
Arthritis Res Ther. 2014 Sep 26;16(5):444
pubmed: 25256257
Nat Commun. 2015 Feb 19;6:6329
pubmed: 25695838
Arthritis Rheumatol. 2016 Feb;68(2):462-72
pubmed: 26360137
Oncoimmunology. 2015 Oct 29;5(4):e1102828
pubmed: 27141387
Immunity. 2016 May 17;44(5):989-1004
pubmed: 27192565
Nat Commun. 2016 May 20;7:11639
pubmed: 27198196
J Autoimmun. 2017 Jan;76:75-84
pubmed: 27653378
Nat Rev Rheumatol. 2016 Nov 22;12(12):716-730
pubmed: 27872476
Clin Exp Immunol. 2017 Apr;188(1):63-78
pubmed: 27880975
Arthritis Res Ther. 2017 May 16;19(1):97
pubmed: 28511719
F1000Res. 2018 Feb 19;7:205
pubmed: 29527301
Brain. 2019 Apr 1;142(4):916-931
pubmed: 30770703
J Immunol. 1995 Aug 1;155(3):1151-64
pubmed: 7636184
Br J Rheumatol. 1996 Mar;35(3):226-30
pubmed: 8620296

Auteurs

Rika Kato (R)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Shuji Sumitomo (S)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yumi Tsuchida (Y)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Haruka Tsuchiya (H)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Shinichiro Nakachi (S)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Keiichi Sakurai (K)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Norio Hanata (N)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yasuo Nagafuchi (Y)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kanae Kubo (K)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Shoko Tateishi (S)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Immunotherapy Management, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Hiroko Kanda (H)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Immunotherapy Management, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Tomohisa Okamura (T)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Max Planck-The University of Tokyo Center for Integrative Inflammology, The University of Tokyo, Tokyo, Japan.

Kazuhiko Yamamoto (K)

Center for Integrative Medical Sciences, The Institute of Physical and Chemical Research, Yokohama, Japan.

Keishi Fujio (K)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH